What is synergy? The Saariselkä agreement revisited

Frontiers in Pharmacology

Volumn 6, Issue SEP, 2015, Pages

  Tang, Jing ^a   Wennerberg, Krister ^a   Aittokallio, Tero ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Bliss and Loewe models; Consensus agreement; Definition of synergy; Drug combinations; Interaction barometer

Indexed keywords

BLISS INDEPENDENCE MODEL; CONSENSUS DEVELOPMENT; DRUG COMBINATION; DRUG EFFICACY; DRUG INTERACTION; DRUG POTENTIATION; LOEWE ADDITIVITY MODEL; MEDICAL TERMINOLOGY; MODEL; NULL HYPOTHESIS; PRACTICE GUIDELINE; SHORT SURVEY; STANDARDIZATION; STATISTICAL ANALYSIS;

EID: 84944751925     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00181     Document Type: Short Survey

References (32)

1. Berenbaum, M. C. (1989). What is synergy? Pharmacol. Rev. 41, 93-141.
2. Bliss, C. I. (1939). The toxicity of poisons applied jointly1. Ann. Appl. Biol. 26, 585-615. doi: 10.1111/j.1744-7348.1939.tb06990.x
3. Breitinger, H.-G. (2012). "Drug synergy-mechanisms and methods of analysis," in Toxicity and Drug Testing, ed B. Acree (Rijeka: InTech), 143-166.
4. Bunterngsook, B., Eurwilaichitr, L., Thamchaipenet, A., and Champreda, V. (2015). Binding characteristics and synergistic effects of bacterial expansins on cellulosic and hemicellulosic substrates. Bioresour. Technol. 176, 129-135. doi: 10.1016/j.biortech.2014.11.042
5. Chevereau, G., and Bollenbach, T. (2015). Systematic discovery of drug interaction mechanisms. Mol. Syst. Biol. 11:807. doi: 10.15252/msb.20156098
6. Chou, T.-C. (2006). Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58, 621-681. doi: 10.1124/pr.58.3.10
7. Chou, T.-C. (2010). Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70, 440-446. doi: 10.1158/0008-5472.CAN-09-1947
8. Cokol, M., Chua, H. N., Tasan, M., Mutlu, B., Weinstein, Z. B., Suzuki, Y., et al. (2011). Systematic exploration of synergistic drug pairs. Mol. Syst. Biol. 7:544. doi: 10.1038/msb.2011.71
9. Darling, E. S., and Côté, I. M. (2008). Quantifying the evidence for ecological synergies. Ecol. Lett. 11, 1278-1286. doi: 10.1111/j.1461-0248.2008.01243.x
10. Drescher, K., and Boedeker, W. (1995). Assessment of the combined effects of substances: the relationship between concentration addition and independent action. Biometrics 51, 716-730. doi: 10.2307/2532957
11. Dressler, V., Müller, G., and Sühnel, J. (1999). CombiTool-a new computer program for analyzing combination experiments with biologically active agents. Comput. Biomed. Res. Int. J. 32, 145-160. doi: 10.1006/cbmr.1999.1509
12. Fitzgerald, J. B., Schoeberl, B., Nielsen, U. B., and Sorger, P. K. (2006). Systems biology and combination therapy in the quest for clinical efficacy. Nat. Chem. Biol. 2, 458-466. doi: 10.1038/nchembio817
13. Goldoni, M., and Johansson, C. (2007). A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model. Toxicol. In Vitro 21, 759-769. doi: 10.1016/j.tiv.2007.03.003
14. Greco, W., Unkelbach, H.-D., Pöch, G., Sühnel, J., Kundi, M., and Bödeker, W. (1992). Consensus on concepts and terminology for combined action assessment: the saariselkä agreement. Arch. Complex Environ. Stud. 4, 65-69.
15. Greco, W. R., Bravo, G., and Parsons, J. C. (1995). The search for synergy: a critical review from a response surface perspective. Pharmacol. Rev. 47, 331-385.
16. Hu, J., Arantes, V., and Saddler, J. N. (2011). The enhancement of enzymatic hydrolysis of lignocellulosic substrates by the addition of accessory enzymes such as xylanase: is it an additive or synergistic effect? Biotechnol. Biofuels 4:36. doi: 10.1186/1754-6834-4-36
17. Kashif, M., Andersson, C., Åberg, M., Nygren, P., Sjöblom, T., Hammerling, U., et al. (2014). A pragmatic definition of therapeutic synergy suitable for clinically relevant in vitro multicompound analyses. Mol. Cancer Ther. 13, 1964-1976. doi: 10.1158/1535-7163.MCT-13-0430
18. Kong, M., and Lee, J. J. (2006). A generalized response surface model with varying relative potency for assessing drug interaction. Biometrics 62, 986-995. doi: 10.1111/j.1541-0420.2006.00579.x
19. Laskey, S. B., and Siliciano, R. F. (2014). A mechanistic theory to explain the efficacy of antiretroviral therapy. Nat. Rev. Microbiol. 12, 772-780. doi: 10.1038/nrmicro3351
20. Lee, J. J., Kong, M., Ayers, G. D., and Lotan, R. (2007). Interaction index and different methods for determining drug interaction in combination therapy. J. Biopharm. Stat. 17, 461-480. doi: 10.1080/10543400701199593
21. Lee, S.-I. (2010). Drug interaction: focusing on response surface models. Korean J. Anesthesiol. 58, 421-434. doi: 10.4097/kjae.2010.58.5.421
22. Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., et al. (2009). Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat. Biotechnol. 27, 659-666. doi: 10.1038/nbt.1549
23. Loewe, S. (1953). The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3, 285-290.
24. Miller, M. L., Molinelli, E. J., Nair, J. S., Sheikh, T., Samy, R., Jing, X., et al. (2013). Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets. Sci. Signal. 6:ra85. doi: 10.1126/scisignal.2004014
25. Piggott, J. J., Townsend, C. R., and Matthaei, C. D. (2015). Reconceptualizing synergism and antagonism among multiple stressors. Ecol. Evol. 5, 1538-1547. doi: 10.1002/ece3.1465
26. Shafer, S. L., Hendrickx, J. F., Flood, P., Sonner, J., and Eger, E. I. II. (2008). Additivity versus synergy: a theoretical analysis of implications for anesthetic mechanisms. Anesth. Analg. 107, 507-524. doi: 10.1213/ane.0b013e31817b7140
27. Sucher, N. J. (2014). Searching for synergy in silico, in vitro and in vivo. Synergy 1, 30-43. doi: 10.1016/j.synres.2014.07.004
28. Tallarida, R. J. (2006). An overview of drug combination analysis with isobolograms. J. Pharmacol. Exp. Ther. 319, 1-7. doi: 10.1124/jpet.106.104117
29. Yeh, P., Tschumi, A. I., and Kishony, R. (2006). Functional classification of drugs by properties of their pairwise interactions. Nat. Genet. 38, 489-494. doi: 10.1038/ng1755
30. Zhang, J., and Viikari, L. (2014). Impact of xylan on synergistic effects of xylanases and cellulases in enzymatic hydrolysis of lignocelluloses. Appl. Biochem. Biotechnol. 174, 1393-1402. doi: 10.1007/s12010-014-1140-7
31. Zhao, L., Au, J. L., and Wientjes, M. G. (2010). Comparison of methods for evaluating drug-drug interaction. Front. Biosci. Elite Ed. 2, 241-249. doi: 10.2741/e86
32. Zhao, W., Sachsenmeier, K., Zhang, L., Sult, E., Hollingsworth, R. E., and Yang, H. (2014). A new bliss independence model to analyze drug combination data. J. Biomol. Screen. 19, 817-821. doi: 10.1177/1087057114521867